Intentar ORO - Gratis
Government's Nano approach for pharma industry
Bio Spectrum
|Decemeber 2019
Nanotechnology is now known to be the game-changer when it comes dealing with the rising burden of various life-threatening diseases such as cancer, diabetes, cardiovascular diseases along with others.
There are no specific guidelines for development and evaluation of nanopharmaceuticals in India. There is a need to formulate comprehensive guideline focusing on the quality, safety and efficacy of nanopharmaceuticals for their therapeutics use.
Keeping this in mind and with an aim of supporting, coordinating and advancing the nanotechnology-based research in India, Department of Biotechnology (DBT), Ministry of Science and Technology, Indian Council of Medical Research (ICMR) and Central Drugs Standard Control Organization (CDSCO), Ministry of Health and Family Welfare have rolled out the first guidelines for the sector ‘Guidelines for Evaluation of Nanopharmaceuticals in India’ on October 24. It is an outcome of all concerned Inter-Ministerial efforts coordinated by DBT.
Releasing the document Dr. Harsh Vardhan, Union Minister for Science & Technology, Earth Sciences and Health & Family Welfare informed that these “Guidelines for Evaluation of Nanopharmaceuticals in India” is one of the most important steps for delineating quality, safety and efficacy assessment of the novel nanoformulations. These guidelines are intended to provide transparent, consistent and predictable regulatory pathways for nanopharmaceuticals in India.”
Esta historia es de la edición Decemeber 2019 de Bio Spectrum.
Suscríbete a Magzter GOLD para acceder a miles de historias premium seleccionadas y a más de 9000 revistas y periódicos.
¿Ya eres suscriptor? Iniciar sesión
MÁS HISTORIAS DE Bio Spectrum
Bio Spectrum
Syngene strengthens leadership team with 2 key appointments
Syngene International, a global contract research, development, and manufacturing organisation (CRDMO), has announced the appointment of Maninder Kapoor Puri as Chief Human Resources Officer (CHRO) and Abhijit Zutshi as Chief Commercial Officer (CCO), effective May 1, 2026.
1 min
June 2026
Bio Spectrum
NIScPR signs MoU with RIS to strengthen science, technology, innovation, policy and diplomacy
To strengthen cooperation in the fields of science, technology, innovation, policy, and diplomacy, the National Institute of Science Communication and Policy Research (NISCPR) has signed a Memorandum of Understanding with the Research and Information System for Developing Countries (RIS).
1 min
June 2026
Bio Spectrum
Gaurav Jain steps into COO role at Redcliffe Labs
Redcliffe Labs has announced that Gaurav Jain has taken on the role of Chief Operating Officer (COO), marking a key leadership milestone as the company continues to scale its operations and strengthen its technology-led, consumer-first diagnostics ecosystem to make preventive diagnostics more accessible, affordable, accurate, and actionable across India.
1 min
June 2026
Bio Spectrum
ABEC expands Process Sciences Group to strengthen bioprocess optimisation capabilities
ABEC, a global leader in bioprocess engineering solutions, has announced the expansion of its Process Sciences group, expanding its ability to help biopharmaceutical manufacturers accelerate development, reduce risk, and improve productivity across the bioprocess lifecycle.
1 min
June 2026
Bio Spectrum
Amneal Pharma buys Kashiv BioSciences to create fully integrated global biosimilar leader
Kashiv BioSciences has entered into a definitive agreement to be acquired by Amneal Pharmaceuticals, Inc.
1 min
June 2026
Bio Spectrum
Health Ministry unveils comprehensive guidance document on Diabetes Mellitus in children
In a historic step towards strengthening child health services, the Ministry of Health and Family Welfare has released the guidance document on Diabetes Mellitus in children.
1 min
June 2026
Bio Spectrum
“We want to develop mRNA vaccines for the most prevalent cancers in India”
A unique initiative of the Tata Trusts with a mission to support the application of cutting-edge science to solve societal problems, Bengaluru-based Tata Institute for Genetics and Society (TIGS) is deepening its efforts towards developing science-based solutions to prevent diseases and improve access to affordable and quality diagnostics and therapeutics in the country.
5 mins
June 2026
Bio Spectrum
Neuland secures development collaboration with LIR Life Sciences for transdermal GLP-1
Hyderabad-based Neuland Laboratories, a global contract development and manufacturing organisation (CDMO) specialising in complex APIs, has entered into a development partnership with LIR Life Sciences Corp, a Canada-based biotechnology company focused on scalable and accessible obesity treatments, in advancing its cell-penetrating peptide (CPP) platform.
1 min
June 2026
Bio Spectrum
IIT Madras announces $7.5 M Menlo Park deep-tech hub to drive Indian innovation into Silicon Valley
Indian Institute of Technology (IIT) Madras Global Research Foundation has announced the establishment of its first centre in the United States (US), located in Menlo Park, California, marking a significant milestone in expanding India's deep-tech innovation footprint into global ecosystems.
1 min
June 2026
Bio Spectrum
Oxford and Serum Institute of India to advance development of new malaria vaccine candidate
The University of Oxford, through Oxford University Innovation (OUI), and the Serum Institute of India (SII), have entered into a licence agreement to support the development and manufacture of the new malaria vaccine candidate R78C, based on two Plasmodium falciparum blood-stage antigens (RIPR and CyPRA), for use in clinical settings.
1 min
June 2026
Translate
Change font size